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SUMMARY – The aim of the study was to assess biometric factor aberrations and differences 
among groups of eyes with cataract and pseudoexfoliative syndrome, cataract and pseudoexfoliative 
glaucoma, and cataract and primary open-angle glaucoma (POAG), and to determine biometric fac-
tors of the eye specific for the group of glaucomatous patients with pseudoexfoliative syndrome by use 
of optical low-coherence reflectometry. This retrospective study included 72 patients, and the study 
sample of 102 eyes was divided into the following three groups according to diagnosis: 29 eyes with 
pseudoexfoliative syndrome and cataract; 36 eyes with POAG and cataract; and 37 eyes with pseudo-
exfoliative glaucoma and cataract. Data on biometric measurements (central corneal thickness, pupil-
lary diameter, anterior chamber depth, lens thickness, axial length, retinal thickness, astigmatism and 
white-to-white) obtained by use of optical low-coherence reflectometry on a Lenstar LS 900® (Haag-
Streit International) were collected and analyzed by thorough survey of medical documentation of 
patients scheduled for cataract surgery at Department of Ophthalmology, Sveti Duh University Hos-
pital in Zagreb, Croatia. Comparative analysis of the groups yielded statistically significant differ-
ences in central corneal thickness (F2/99=7.066; p=0.001) and lens thickness (F2/96=5.133; p=0.008). 
The group of eyes diagnosed with pseudoexfoliative glaucoma and cataract had a significantly thinner 
cornea as compared with the other two groups and a significantly thicker lens as compared with the 
group of eyes with POAG and cataract. In conclusion, optical low-coherence reflectometry revealed 
differences in biometric factors among the three groups of eyes, with a statistically significantly thin-
ner cornea and thicker lens in the group of glaucomatous patients with pseudoexfoliative syndrome.
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Introduction
Pseudoexfoliative (PEX) syndrome is a generalized 
disorder of the extracellular matrix characterized by 
the production and accumulation of fibril granulated 
protein (exfoliative material) in the anterior eye seg-
ment tissues and connective tissue of visceral organs1-4. 
PEX syndrome is a disorder associated with older age, 
found all over the world population, however, with 
great ethnic and geographical differences in its preva-
lence. The average age at its onset across the popula-
tions is ≥60 years, while the average prevalence is esti-
mated to 10%-20%. In the eye, PEX syndrome mani-
fests as the presence of pseudoexfoliative material de-
posits on the anterior lens capsule, ciliary body, zonules, 
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pupillary edge, corneal endothelium, anterior vitreous, 
trabeculum and connective tissue in the eyeball4-7. The 
etiopathogenesis of the syndrome has not yet been 
fully clarified, but it is known to involve both genetic 
and non-genetic factors. Recent research supports the 
pathogenetic concept of PEX syndrome as a form of 
stress induced systemic elastosis associated with over-
production and progressive accumulation of fibrillar 
material in the anterior eye segment tissues and con-
nective tissue of visceral organs (liver, lung, heart, kid-
ney and vascular walls). Several genes have been recog-
nized as most responsible for development of PEX 
syndrome, in particular lysyl oxidase-like 1 (LOXL1) 
gene polymorphism on chromosome 15q24.1 in the 
populations investigated, with a contribution of addi-
tional genes with relatively small effects (clustrein, 
contactin associated protein-like 2 (CNTNAP2), apo-
lipoprotein E, glutathione S-transferase, adenosine, 
and tumor necrosis factor-alpha (TNF-α)). LOXL1 
polymorphism is related to the action of profibrillar 
transforming growth factor-beta (TGF-β) and tissue 
inhibitors of metalloproteinases (TIMPs) with conse-
quential progressive production and accumulation of 
PEX material. Current concepts also confirm the ef-
fect of oxidative stress in the genesis of PEX syndrome, 
as well as impaired cellular self-defense, along with 
reduced levels of tissue antioxidants, leading to im-
paired matrix metabolism and inducing proinflamma-
tory state8,9. Pathologic production and deposition of 
PEX material has been associated with development 
of intraocular complications (corneal endotheliopathy, 
iridopathy with reduced pupillary opening, ciliary 
body alterations, instability and degenerative changes 
of zonular apparatus, increased lens mobility, lens or 
intraocular graft decentration and dislocation, pig-
ment dispersion, secondary open-angle and angle-clo-
sure glaucoma, pseudouveitis, anterior synechiae, and 
anterior chamber hypoxia). The condition poses an in-
creased risk of intraoperative complications (lesions of 
zonular apparatus, rupture of lens capsule, loss of vitre-
ous, prolonged time of postoperative inflammatory 
reaction, and postoperative elevation of intraocular 
pressure)7,10-13. PEX syndrome poses a four-fold great-
er risk of glaucoma14. In the presence of PEX syn-
drome, glaucoma develops in 15%-20% of cases within 
10 years. According to the onset mechanism, it is sec-
ondary open-angle or angle-closure glaucoma, both 
showing progressive course and poor therapeutic re-
sponse. PEX glaucoma develops as secondary open-
angle glaucoma in 15%-20% of open-angle glaucoma 
cases. Accumulation of PEX material and pigment in 
chamber angle, as well as morphological changes in 
the trabecular space, Schlemm’s canal, juxtacanalicular 
space, presence of synechiae, iridal tissue atrophy, 
weakness of zonular apparatus, increased lens mobility 
and lens forward migration, and ciliary block condi-
tion increase resistance to aqueous humor circulation 
and drainage, and increase intraocular pressure in the 
eye with PEX syndrome1,10. Modern operative tech-
niques employed in cataract surgery and refractive sur-
gery, and use of new-generation biometric formulas to 
calculate intraocular lens strength require extensive 
and accurate preoperative biometric ophthalmologic 
status in order to achieve the best possible postopera-
tive results. Previous studies using various biometric 
methods attempted to explain the relationships be-
tween biometric aberrations and pathophysiological 
events in the eye with PEX syndrome and PEX glau-
coma, and their effect on the occurrence of intra- and 
postoperative complications. It is well known that 
PEX syndrome is one of the most common causes of 
complications in cataract surgery, whereas the results 
of previous studies on biometric factor aberrations in 
the eye with PEX syndrome with or without glaucoma 
are contradictory.
Aberrations in the values of biometric factors such 
as lower anterior chamber depth (ACD), lower pupil-
lary diameter (PD) and higher lens thickness (LT) 
point to zonular apparatus instability, presence of syn-
echiae, forward lens migration and increased mobility 
of the lens or intraocular artificial lens implant13,15. 
Preoperative detection of biometric factor aberrations 
enables assessment of the risk of intra- and postopera-
tive complications in cataract and glaucoma surgery, 
and the need of operative technique and intraocular 
artificial lens implant adjustment.
The aim and purpose of the present study was to 
determine biometric factors of the eye specific for the 
group of glaucomatous patients with PEX syndrome 
and variation in biometric factors among the study 
groups of eyes by use of optical low-coherence reflec-
tometry (OLCR), and to define the role of OLCR in 
the diagnosis of glaucomatous patients with PEX syn-
drome. OLCR is a non-contact, noninvasive biometric 
method providing extensive biometric status by simul-
taneous measurement of central corneal thickness 
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(CCT), ACD, corneal curvature radius (K1 and K2 
keratometry), PD, astigmatism (AST), white-to-white 
corneal diameter (WTW), axial length of the eye 
(AL), LT and retinal thickness (RT).
Patients and Methods
The investigation was designed as a retrospective, 
observational study aiming to compare the results of 
biometric measurements performed by OLCR in dif-
ferent study samples. Data were collected from medi-
cal documentation on patients scheduled for cataract 
surgery at Department of Ophthalmology, Sveti Duh 
University Hospital in Zagreb, Croatia. Three groups 
of eyes based on the preset characteristics were estab-
lished, using the inclusion/exclusion criteria: eyes with 
PEX syndrome and cataract; eyes with PEX glaucoma 
and cataract; and eyes with primary open-angle glau-
coma (POAG) and cataract. Results of preoperative 
biometric measurements obtained by OLCR on a 
Lenstar LS 900® (Haag-Streit International, Köniz, 
Switzerland) were analyzed. The study included 102 
eyes of 72 patients (44 female and 28 male) older than 
40, examined before cataract surgery. There were 29 
eyes with PEX syndrome and cataract; 36 eyes with 
POAG and cataract; and 37 eyes with PEX glaucoma 
and cataract.
Inclusion criteria
•	 Presence of POAG and cataract
•	 Presence of anterior eye segment lesions typical 
for PEX syndrome (PEX material on pupillary 
margin and lens capsule) along with the pres-
ence of cataract but free from lesions typical for 
glaucoma
•	 Presence of lesions in the anterior eye segment 
and chamber angle typical for PEX syndrome, 
with medical history and signs of glaucoma and 
cataract
Exclusion criteria
•	 Patients scheduled for cataract surgery diagno-
sed with cataract and other pathologic or post-
traumatic eye lesions during the process of pre-
operative biometric diagnostics, and patients 
diagnosed with another form of primary or sec-
ondary glaucoma in addition to cataract
Medical documentation of each patient contained 
the following data necessary for the study:
- medical history (data on age, sex, presence/ab-
sence of eye disease prior to cataract surgery and 
on previous diseases)
- ophthalmologic status (visual acuity, biomicros-
copy results, intraocular pressure value measured 
by applanation tonometry, results of fundus ex-
amination by direct and indirect ophthalmosco-
py, visual field changes described, and quantita-
tive results of biometric measurements carried 
out by OLCR on a Lenstar LS 900® (Haag-
Streit International, Köniz, Switzerland).
Lenstar LS 900® (Haag-Streit International, 
Köniz, Switzerland) is an optical biometer using 820 
nm superluminescent diode as a source of coaxial in-
frared rays, has a spectrum range of 20-30 nm and 
short 30-μm coherence, resulting in high spatial reso-
lution. The device provides thorough biometric status 
by simultaneous measurement of CCT, ACD, K1 and 
K2, PD, AST, WTW, AL, LT and RT. The method is 
non-contact, noninvasive, rapid, painless, and cannot 
be performed in case of nontransparent optical media 
(e.g., complete lens opacity, vitreous hemorrhage or 
retinal detachment).
Ethics
The use of patient medical documentation and 
study design were approved by Ethics Committee of 
Sveti Duh University Hospital, Zagreb.
Statistics
In order to get answers to the questions posed in 
the study, we used statistical tests to compare the mean 
results recorded in the three groups of eyes (eyes with 
PEX syndrome and cataract; eyes with PEX glaucoma 
and cataract; and eyes with POAG and cataract) for 
the study parameters (AL, ACD, K1, K2, AST, LT, 
CCT, RT, PD and WTW). Depending on the normal 
or non-normal data distribution, analysis of variance 
(normal data distribution) or Kruskal-Wallis test 
(non-normal data distribution) was performed, both 
intended to test the level of statistical significance 
when comparing more than two groups. We also ana-
lyzed differences in the measured values within par-
ticular groups according to age and sex. Depending on 
data distribution, we used analysis of variance (normal 
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data distribution) or Kruskal-Wallis test (non-normal 
data distribution). Results of these tests showed 
whether there were age and sex differences in the mean 
measured values for a particular diagnosis. The level of 
statistical significance was set at 5%.
Results
The study included 102 eyes of 72 patients (44 fe-
male and 28 male). Female predominance was higher 
in the PEX syndrome/cataract group (63.6% female 
and 27.4% male) and POAG/cataract group (63.0% 
female and 27.0% male) as compared with the PEX 
glaucoma/cataract group (54.5% female and 36.5% 
male); however, this difference did not reach statistical 
significance (χ2=0.486; ss=2; p=0.784). The mean age 
was 79.61±6.50 and 79.41±5.27 years in the PEX syn-
drome/cataract and PEX glaucoma/cataract groups, 
respectively. In the POAG/cataract group, the mean 
age was younger (70.81±7.80 years). Patient age dif-
fered statistically significantly according to diagnosis 
(F2/69=14.204; p<0.001). Statistically significant dif-
ferences were recorded between the PEX syndrome/
cataract and POAG/cataract groups and between the 
PEX glaucoma/cataract and POAG/cataract groups 
(Scheffe test, p<0.001 both) (Fig. 1). There was no age 
difference between patients diagnosed with PEX syn-
drome/cataract and those with PEX glaucoma/cata-
ract (Scheffe test, p=0.995). Analysis of biometric sta-
tus of eyes diagnosed with PEX syndrome/cataract 
according to age yielded significant correlation only 
with LT (r=0.564; p=0.008), i.e. older patients had a 
statistically significantly higher LT value.
Comparison according to sex yielded a statistically 
significant difference in pupillometry results (t=2.474; 
ss=20; p=0.022), i.e. women showed higher mean PD 
as compared with men (M=5.7±1.103 mm vs. 
M=4.6±0.855 mm). In the POAG/cataract group, nei-
ther age nor sex difference reached statistical signifi-
cance. Analysis of biometric status of the eyes diag-
nosed with PEX glaucoma/cataract according to age 
showed statistically significant correlation with LT 
(r=0.472; p=0.027) and WTW (r=0.512; p=0.015). 
Older patients had thicker lens and smaller corneal di-
ameter. Testing according to sex yielded no statistically 
significant differences. Comparative analysis of bio-
metric factors measured in all study groups (PEX syn-
drome/cataract, POAG/cataract and PEX glaucoma/
Fig. 1. Patient mean age according to diagnosis.
PEX+cataract = pseudoexfoliative syndrome and cataract; POAG+ 
cataract = primary open-angle glaucoma and cataract; PEX glau-
coma+cataract = pseudoexfoliative glaucoma and cataract
Fig. 2. Comparison of central corneal thickness mean 
values according to study groups.
PEX + cataract = pseudoexfoliative syndrome and cataract; POAG 
+ cataract = primary open-angle glaucoma and cataract; PEX glau-
coma + cataract = pseudoexfoliative glaucoma and cataract
Fig. 3. Comparison of lens thickness mean values 
according to study groups.
PEX + cataract = pseudoexfoliative syndrome and cataract; POAG 
+ cataract = primary open-angle glaucoma and cataract; PEX glau-
coma + cataract = pseudoexfoliative glaucoma and cataract
cataract) revealed statistically significant differences in 
CCT (F2/99=7.066; p=0.001) and LT (F2/96=5.133; 
p=0.008) (Table 1). The eyes diagnosed with PEX syn-
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drome/cataract had a statistically significantly greater 
CCT than those diagnosed with PEX glaucoma/cata-
ract (564.6±39.54 μm vs. 531.4±8.95 μm; Scheffe test, 
p=0.002). Other CCT differences did not reach statis-
tical significance (POAG/cataract vs. PEX glaucoma/
cataract: Scheffe test, p=0.081; and PEX syndrome/
cataract vs. POAG/cataract: Scheffe test, p=0.302) 
(Fig. 2). Analysis of the results showed the eyes diag-
nosed with PEX syndrome/cataract and those with 
PEX glaucoma/cataract to have a statistically signifi-
cantly thicker lens than the eyes diagnosed with 
POAG/cataract (4.7±0.444 mm and 4.7±0.417 mm, 
respectively vs. 4.4±0.417 mm; Scheffe test, p=0.041 
and p=0.018, respectively). Lens thickness did not dif-
fer between the eyes diagnosed with PEX syndrome/
cataract and those with PEX glaucoma/cataract 
(Scheffe test, p=0.995) (Fig. 3).
Discussion
Assessment of biometric status of the eye has a ma-
jor role in cataract, glaucoma and refractive surgery. 
The use of new generation biometric formulas requires 
thorough analysis of biometric measures in the eye in 
order to achieve the best possible postoperative results. 
Furthermore, previous studies have documented the 
relationship of aberrations in particular biometric fac-
tors with a higher risk of intra- and postoperative 
complications in cataract surgery. Knowing the bio-
metric status of the eye in detail is a precondition for 
successful operative course prediction, adjustment and 
selection of operative techniques and intraocular arti-
ficial lens implants, and for postoperative result assess-
ment. PEX syndrome is a disorder of the elderly, fre-
quently associated with development of cataract and 
glaucoma.
Our study included 102 eyes in 72 patients (44 fe-
male and 28 male), clearly showing female predomi-
nance (60.6%), which could be explained by demo-
graphic characteristics of the population and greater 
proportion of women in the elderly population in gen-
eral. The prevalence of PEX syndrome is known to be 
higher in women, whereas PEX glaucoma occurs more 
frequently in men5,6. In the present study, the propor-
tion of women was greater in the PEX syndrome/cata-
ract and POAG/cataract groups (63%) as compared 
with the PEX glaucoma/cataract group (55%). In the 
latter, the proportion of men was higher as compared 
with the other two groups; however, the difference was 
not statistically significant (χ2=0.486; ss=2; p=0.784).
The mean patient age was significantly higher in 
the PEX syndrome/cataract and PEX glaucoma/cata-
ract groups (79.61±6.50 and 79.41±5.27 years, respec-
tively) as compared with the POAG/cataract group 
(70.81±7.80 years) (Scheffe test, p<0.001). The results 
obtained are consistent with literature data on the risk 
of PEX syndrome and PEX glaucoma to rise with age. 
The incidence of PEX syndrome is on an increase with 
Table 1. Comparative analysis of biometric factors according to study groups
PEX syndrome + cataract POAG + cataract PEX glaucoma + cataract F; df; pn M SD n M SD n M SD
AL 27 22.8 0.771 35 22.9 1.092 30 23.0 0.819 0.599; 2/89; 0.703
CCT 29 564.6 39.547 36 550.6 29.243 37 531.4 38.951 7.066; 2/99 0.001**
ACD 29 2.3 0.397 36 2.5 0.395 36 2.4 0.551 1.258; 2/98; 0.289
LT 27 4.7 0.444 36 4.4 0.417 36 4.7 0.435 5.133; 2/96; 0.008**
K2 29 43 1.299 36 43.5 1.742 37 43.2 1.143 0.894; 2/99; 0.412
K1 29 43.9 1.330 36 44.2 1.843 37 44.2 1.132 0.638; 2/99; 0.530
AST 29 0.9 0.465 36 2.1 7.716 37 1.0 0.591 3.519; 2; 0.172#
WTW 29 12.0 0.495 36 11.9 0.634 36 11.8 0.702 1.369; 2/98; 0.259
PD 29 5.2 1.194 35 5.1 1.329 32 4.6 0.927 2.732; 2/93; 0.07
PEX syndrome = pseudoexfoliative syndrome; POAG = primary open-angle glaucoma; PEX glaucoma = pseudoexfoliative glaucoma; AL 
= axial length; CCT = central corneal thickness; ACD = anterior chamber depth; LT = lens thickness; K1 = keratometry of the steepest 
meridian; K2 = keratometry of the flattest meridian; AST = astigmatism; WTW = horizontal corneal diameter (white-to-white); PD = 
pupillary diameter; n = number of patients; M = arithmetic mean; SD = standard deviation; F = analysis of variance; df = degrees of freedom; 
p = probability of error; **p<0.01; #Kruskal-Wallis test
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population aging worldwide5,6. PEX syndrome is a 
generalized disorder that involves almost all segments 
of the eye, mostly bilaterally. It develops gradually and 
the lesions are considered to occur much earlier than 
becoming clinically visible on the lens capsule and pu-
pillary opening. Therefore, it is of utmost importance 
to support development of diagnostic methods to di-
rectly or indirectly point to lesions in the earlier stage 
of the disease. Previous studies employing various bio-
metric methods have reported contradictory results on 
biometric characteristics of the eye with PEX syn-
drome and PEX glaucoma.
In our sample of eyes divided into three groups, we 
recorded statistically significant CCT differences be-
tween the PEX syndrome/cataract and PEX glauco-
ma/cataract groups (564.6±39.54 μm vs. 531.4±38.95 
μm; Scheffe test, p=0.002). The group of eyes diag-
nosed with PEX glaucoma and cataract had a signifi-
cantly thinner cornea as compared with the other two 
groups. Using ultrasound (US) pachymetry and com-
parison of samples of normotensive and PEX syn-
drome eyes with and without glaucoma, Puska et al. 
report on significantly higher CCT values in patients 
with PEX syndrome16. Results consistent to ours have 
been published by Bechmann et al.; using optical co-
herence tomography, they point to lower CCT values 
measured in patients with PEX glaucoma17. In con-
trast, Arnarsson et al. (Reykjavik Eye Study) found no 
association between the presence of PEX syndrome 
and aberrations in CCT, ACD and LT values5. Using 
the Pentacam Scheimpflug imaging system, Doganay 
et al. found no CCT and PD differences among pa-
tients with PEX glaucoma, those with PEX syndrome 
and control group18,19. Rufer et al. recorded no statisti-
cally significant differences, whereas Inoue et al. report 
on thinner cornea in patients with PEX syndrome 
with or without glaucoma as compared with control 
group, but found no statistically significant difference 
between the PEX syndrome and PEX glaucoma 
groups. They report on the association between re-
duced corneal endothelial cell count and decreased 
CCT value in patients with PEX glaucoma20,21. The 
onset of PEX syndrome is known to be accompanied 
by corneal lesions that manifest as alterations of the 
corneal epithelial, stromal and endothelial cells, as well 
as of Descemet’s membrane of the cornea. These al-
terations include changes in the cell number and mor-
phology that occur due to metabolic changes, produc-
tion and accumulation of PEX material, and changes 
in aqueous humor, resulting in cell disintegration, mi-
gration, uncontrolled proliferation and eventually 
apoptosis, with aggravation of these alterations in the 
presence of elevated intraocular pressure20-23. Corneal 
lesions in PEX syndrome can cause corneal decom-
pensation and are a major factor in the assessment of 
postoperative results.
In the present study, patients diagnosed with PEX 
syndrome/cataract and those with PEX glaucoma/
cataract had a statistically significantly thicker lens 
than patients diagnosed with POAG/cataract (4.7± 
0.444 mm and 4.7±0.417 mm vs. 4.4±0.417 mm, re-
spectively; Scheffe test, p=0.041 and p=0.018, respec-
tively). Lens thickness did not differ between patients 
with PEX syndrome/cataract and those with PEX 
glaucoma/cataract (Scheffe test, p=0.995). The lens 
grows with age and the mentioned differences can in 
part be explained by advanced age of patients in the 
groups with PEX syndrome with and without glauco-
ma; however, lens surface in PEX syndrome is known 
to manifest structural central and peripheral altera-
tions. Formation of a precapsular layer made of profi-
brillar material, followed by formation of a layer con-
sisting of organized PEX material and pigment has 
been identified by electron microscopy and histochem-
istry. Localized accumulation of PEX material and de-
generative changes resulting in disintegration at cap-
sular holder occur in the area of zonule insertion. Ten-
sion and contact between the lens capsule and zonule 
decrease with weakness of the zonular apparatus, ren-
dering the lens thicker and ever more mobile. Using 
US biomicroscopy, Unsal et al. detected thicker lens 
and degenerative changes at the zonule capsular hold-
er in the eye with PEX syndrome, unlike the other eye 
without PEX syndrome23. Some literature reports 
speculate that weakness of the zonular apparatus and 
increased lens thickness may cause lens anteposition-
ing and decreased depth of the anterior chamber. These 
changes pose a risk of chamber angle closure and onset 
of glaucoma in PEX syndrome, as well as of intra- and 
postoperative complications in cataract surgery10-13. 
Increased lens thickness leads to closer iridolental con-
tact and potential formation of adhesions, which will 
also result in increased resistance to aqueous humor 
drainage and development of glaucoma. These altera-
tions, as well as epithelial and stromal changes of the 
ciliary muscle and iris are additional factors contribut-
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ing to the inability of adequate mydriasis and reduced 
pupillometry in cataract surgery, thus increasing the 
risk of intra- and postoperative complications. Em-
ploying OLCR, Bosnar et al. found statistically sig-
nificantly lower ACD and PD values and a statisti-
cally significantly thicker lens in the sample of eyes 
with PEX syndrome and cataract as compared with 
the eyes with cataract15. Naumann confirmed lower 
PD values in the eyes with PEX syndrome24. In our 
study, comparative analysis of study groups yielded no 
statistically significant differences in the measured PD 
and ACD values, although the mean ACD value was 
below 2.5 mm in the groups with PEX syndrome/
cataract and PEX glaucoma/cataract (2.3±0.397 mm 
and 2.4±0.551 mm, respectively), which could in part 
be explained by greater lens thickness and inadequate 
response to medicamentous mydriasis due to the iris 
and zonular apparatus alterations described above.
Küchle et al. report that ACD <2.5 mm correlates 
with a fourfold greater risk of intraoperative complica-
tions12. Pupillometry was lowest in the PEX glauco-
ma/cataract group (4.6±0.92 mm) as compared with 
POAG/cataract group (5.1±1.32 mm) and PEX syn-
drome/cataract group (5.2±1.194 mm), however, with-
out statistical significance (F=2.732; ss=2/93; p=0.07). 
Smaller pupillary diameter points to possible associa-
tion with structural changes of iris tissue, presence of 
iridolental adhesions, glaucoma, and greater likelihood 
of intraoperative complications. On analysis of bio-
metric status according to age, a statistically significant 
correlation was recorded for LT (r=0.472; p=0.027) 
and WTW (r=0.512; p=0.015) in the PEX glaucoma/
cataract group. Older patients had thicker lens and 
smaller corneal diameter. WTW is an indirect indica-
tor of iris diameter, lens capsule diameter, ciliary sulcus 
and anterior chamber depth, and in this case an im-
portant factor in the assessment of intraocular lens 
choice and positioning.
Conclusion
Using OLCR, we found differences in the values of 
biometric factors among the study groups, and a statis-
tically significantly thinner cornea and thicker lens in 
the group of glaucomatous patients with PEX syn-
drome. Our results confirmed OLCR as a biometric 
method in preoperative diagnosis to help in detecting 
glaucomatous patients with PEX syndrome. The pur-
pose of the study was to instigate scientific ideas in 
search for novel methods to diagnose specificities of 
ocular biometric factors in glaucomatous patients with 
PEX syndrome.
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Sažetak
SPECIFIČNOSTI BIOMETRIJSKIH ČIMBENIKA OKA U GLAUKOMSKIH BOLESNIKA  
S PSEUDOEKSFOLIJATIVNIM SINDROMOM MJERENIH OPTIČKOM  
NISKOKOHERENTNOM REFLEKTOMETRIJOM
Ž. Janjetović, M. Bušić, D. Bosnar, J. Barać i I. Genda
Cilj je bio optičkom niskokoherentnom reflektometrijom utvrditi odstupanja i razlike biometrijskih čimbenika između 
skupina ispitivanih uzoraka očiju s kataraktom i pseudoeksfolijativnim sindromom, kataraktom i pseudoeksfolijativnim 
 glaukomom i kataraktom i primarnim glaukomom otvorenog kuta te odrediti biometrijske čimbenike oka specifične za sku-
pinu glaukomskih bolesnika s pseudoeksfolijativnim sindromom. U retrospektivnu studiju bilo je uključeno 72 ispitanika, a 
uzorak su činila 102 oka podijeljena u tri skupine prema dijagnozi: 29 očiju s pseudoeksfolijativnim sindromom i kataraktom, 
36 očiju s primarnim glaukomom otvorenog kuta i kataraktom, 37 očiju s pseudoeksfolijativnim glaukomom i kataraktom. 
Detaljnom analizom medicinske dokumentacije ispitanika predviđenih za operaciju katarakte u Klinici za očne bolesti Kli-
ničke bolnice Sveti Duh u Zagrebu prikupljeni su i analizirani podaci biometrijskih mjerenja (centralna debljina rožnice, 
promjer zjenice, dubina prednje sobice, debljina leće, aksijalna duljina, debljina rožnice, astigmatizam i horizontalni promjer 
rožnice izmjereni primjenom optičke niskokoherentne reflektometrije na uređaju Lenstar LS 900®, Haag Streit Internatio-
nal). Usporednom analizom skupina zabilježene su statistički značajne razlike za centralnu debljinu rožnice (F2/99=7,066; 
p=0,001) i debljinu leće (F2/96=5,133; p=0,008). Skupina očiju s dijagnozom pseudoeksfolijativnog glaukoma i katarakte 
imala je značajno tanju rožnicu u odnosu na ostale dvije skupine očiju i značajno deblju leću od skupine s primarnim glauko-
mom otvorenog kuta i kataraktom. U zaključku, primjenom optičke niskokoherentne reflektometrije utvrđene su razlike u 
biometrijskim čimbenicima promatranih skupina i statistički značajno tanja rožnica te zadebljana leća u skupini glaukomskih 
bolesnika s pseudoeksfolijativnim sindromom.
Ključne riječi: Eksfolijacijski sindrom; Optička niskokoherentna reflektometrija; Glaukom otvorenog kuta; Katarakta
